Skip to content

Long-term cancer survivors in Germany: prevalence, survival, cure and secondary tumours

Long-term cancer survivors in Germany: prevalence, survival, cure and secondary tumours - PrevSurv

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00038361
Enrollment
9000000
Registered
2026-03-16
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00-C97

Interventions

Group 1: Retrospective analysis of all patients with a cancer diagnosis (ICD-10: C00-C97 excluding C77-C80) since 2000 in Germany (Data of the Center for Cancer Registry Data (ZfKD)
Data according to § 5 BKRG 2009). By default, information is collected on the individual (age at diagnosis, sex) and the cancer (ICD-O-3, ICD-10, and stage, if applicable). The follow-up data includes

Sponsors

Institut für Sozialmedizin und Epidemiologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0 Years to 120 Years

Inclusion criteria

Inclusion criteria: Cancer diagnosis since 01.01.2000

Exclusion criteria

Exclusion criteria: ICD-10: C77-C80, age at diagnosis > 120 years, missing year of death (in deceased patients), invalid input values after data cleansing

Design outcomes

Primary

MeasureTime frame
There are no endpoints in the conventional sense. The aim of the study is to describe and estimate various aspects of long-term survival after cancer, focusing on (1) overall prevalence, (2) survival and cure, and (3) secondary tumours. Cancer diagnoses (both for primary and secondary cancers) must be reported to the relevant cancer registry by law, including the date of diagnosis. Deaths, including the date of death, are regularly recorded in the cancer registries by cross-referencing with the population registers and are therefore included in the data used.

Countries

Germany

Contacts

Public ContactNora Eisemann

Institut für Sozialmedizin und Epidemiologie

nora.eisemann@uksh.de+4945150051219

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026